Exact Mass: 490.2944
Exact Mass Matches: 490.2944
Found 500 metabolites which its exact mass value is equals to given mass value 490.2944
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Jamaicamide C
Macrocarpal I
Macrocarpal J is a constituent of Eucalyptus globulus (Tasmanian blue gum). Constituent of Eucalyptus globulus (Tasmanian blue gum)
12-Hydroxy-13-O-D-glucuronoside-octadec-9Z-enoate
This compound belongs to the family of Alkyl Glycosides. These are lipids containing a glycosyl moiety (one or several units) linked to the hydroxyl group of a fatty alcohol.
12-O-D-Glucuronoside-13-hydroxyoctadec-9Z-enoate
This compound belongs to the family of Alkyl Glycosides. These are lipids containing a glycosyl moiety (one or several units) linked to the hydroxyl group of a fatty alcohol.
10-Hydroxy-octadec-12Z-enoate-9-beta-D-glucuronide
This compound belongs to the family of Alkyl Glycosides. These are lipids containing a glycosyl moiety (one or several units) linked to the hydroxyl group of a fatty alcohol.
9-Hydroxy-10-O-D-glucuronoside-12Z-octadecenoate
This compound belongs to the family of Alkyl Glycosides. These are lipids containing a glycosyl moiety (one or several units) linked to the hydroxyl group of a fatty alcohol.
1-(13Z,16Z-docosadienoyl)-glycero-3-phosphate
1-(13Z,16Z-docosadienoyl)-glycero-3-phosphate is classified as a member of the 1-acylglycerol-3-phosphates. 1-acylglycerol-3-phosphates are lysophosphatidic acids where the glycerol is esterified with a fatty acid at O-1 position. 1-(13Z,16Z-docosadienoyl)-glycero-3-phosphate is considered to be practically insoluble (in water) and acidic. 1-(13Z,16Z-docosadienoyl)-glycero-3-phosphate is a glycerophosphate lipid molecule
LysoPA(22:2(13Z,16Z)/0:0)
LysoPA(22:2(13Z,16Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(22:2(13Z,16Z)/0:0), in particular, consists of one chain of docosadienoic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
N-Arachidonoyl Tryptophan
N-arachidonoyl tryptophan belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Arachidonic acid amide of Tryptophan. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Arachidonoyl Tryptophan is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Arachidonoyl Tryptophan is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
Sapacitabine
(17R,20R)-7beta,20,23,29-tetrahydroxy-28-norlupane-3,16-dione
4-oxo-19alpha,22alpha-dihydroxy-3,24-dinor-2,4-seco-urs-12-ene-2,28-dioic acid
11alpha-O-(2-methylbutanoyl)-12beta-O-acetyl-tenacigenin B|11alpha-O-2-methylbutyryl-12beta-O-acetyltenacigenin B
(3beta,5beta,22R)-22-Ac-3,14,22,25-Tetrahydroxycholest-7-en-6-one
5-O-acetyl-2-C-(cleroda-3,13-dien-15-yl)-beta-L-xylo-3-hexulofuranosonic acid gamma-lactone
3beta-malonyloxy-15-(3-methylvaleryloxy)-ent-labda-7,13E-diene|3beta-malonyloxy-15-<3-methylvaleryloxy>-ent-labda-7,13E-diene
(1beta,3beta,11alpha,22alpha)-22,26-dimethoxyfurosta-5,25(27)-diene-1,3,11-triol
9beta-acetoxy-11beta,12beta-epoxy-3alpha,13alpha-dipropionoxy-1beta,8beta-trinervit-15(17)-ene
(2S)-1-O-palmitoleyl-3-O-beta-D-galactopyranosylglycerol|1-O-palmitoleoyl-3-O-beta-D-galactopyranosyl-sn-glycerol
9alpha,11alpha-epoxy cholest-7-en-beta,5alpha,6beta,19-tetraol-6-acetate|9alpha,11alpha-epoxycholest-7-en-3beta,5alpha,6beta,19-tetraol 6-acetate|9alpha,11alpha-Epoxycholest-7-ene-3beta,5alpha,6beta,19-tetrol 6-acetate
(5alpha,6beta,15beta,22R)-5,6,15,21,22-pentahydroxy-1-oxoergost-24-en-26-oic acid delta-lactone|baimantuoluoline B
(5alpha,6beta,12beta,22R)-5,6,12,21-tetrahydroxy-1-oxoergost-24-en-26,22-olide|(5alpha,6beta,12beta,22R)-5,6,12,21-tetrahydroxy-1-oxowith-24-enolide|baimantuoluoline F
2alpha,5alpha,10beta-triacetoxy-14beta-isobutyryloxytaxa-4(20),11-diene
(17R)-19(18?17)-abeo-2alpha,16beta,18beta,23,24-pentahydroxy-28-norolean-12-en-3-one|stewertiisin B
(22S,23R)-22,23-epoxy-3beta,12alpha,14beta,16beta,25-pentahydroxyergosta-5,7-dien-11-one|formosterol A
3beta,4beta,23,30-tetrahydroxy-24-norolean-12-ene-28-oic acid
(22S,23R)-22,23-epoxy-12alpha,14beta,16beta,25-tetrahydroxyergosta-5,7-diene-3,11-dione|formosterol B
3beta-(3?-O-acetyl-alpha-l-fucopyranosyloxy)pregn-20-en-19-ol|sclerosteroid F
26-nor-11,23-dioxo-5alpha-lanost-8-en-3beta,7beta,15alpha,25-tetrol
(3beta,5alpha,6alpha,9alpha,11beta)-cholest-7-ene-11,19-oxido-3,5,6,9-tetrol 6-acetate|dysideasterol F
(2R,3S,4R,6R)-6-(((1S,3aS,5aR,5bR,9S,11aR,11bS,13aR,13bS)-11a,13a-dimethyl-1,2,3a,4,5b,6,8,9,10,11,11a,11b,12,13,13a,13b-hexadecahydro-1,5a-epoxyfuro[2,3-c]naphtho[1,2-h]chromen-9-yl)oxy)-4-methoxy-2-methyltetrahydro-2H-pyran-3-ol|pentalinonoside|pentalinonside
2(Methylpropanoyl),18,19-Di-Ac-18,19-Epoxy-13(16),14-clerodadiene-2,18,19-triol|2beta-isobutoxy-18xi,19xi-diacetoxy-4xi,17alpha,19alpha,20beta-(-)-cleroda-13(16),14-diene-18,19-oxide
2-(1-oxo-hexadecyl)-1,3,5-trihydroxybenzene triacetate
24?-4-Chloro-3,23-dioxostigmast-4-en-21-oic acid|Kiheisterone E
3-Ac-3,5,6-Trihydroxy-9-oxo-9,11-secocholest-en-11-al
13,14-Dihydro,6-(2-methylpropanoyl),7-angeloyl-6,7-Dihydroxy-3,13-clerodadien-15-oic acid
(1beta,2alpha,3beta,5alpha,20S)-1,3,20-trihydroxy-4,4,14-trimethyl-15-oxopregn-8-en-2-yl 3-methylbutanoate|xylariacin A
Lys Asp Thr Lys
Cys Ile Lys Lys
Cys Lys Ile Lys
Cys Lys Lys Ile
Cys Lys Lys Leu
Cys Lys Leu Lys
Cys Leu Lys Lys
Asp Lys Lys Thr
Asp Lys Thr Lys
Asp Thr Lys Lys
Glu Lys Lys Ser
Glu Lys Ser Lys
Glu Ser Lys Lys
Phe Ile Ile Val
Phe Ile Leu Val
Phe Ile Val Ile
Phe Ile Val Leu
Phe Leu Ile Val
Phe Leu Leu Val
Phe Leu Val Ile
Phe Leu Val Leu
Phe Val Ile Ile
Phe Val Ile Leu
Phe Val Leu Ile
Phe Val Leu Leu
Gly Lys Met Arg
Gly Lys Arg Met
Gly Met Lys Arg
Gly Met Arg Lys
Gly Arg Lys Met
Gly Arg Met Lys
His His Val Val
His Val His Val
His Val Val His
Ile Cys Lys Lys
Ile Phe Ile Val
Ile Phe Leu Val
Ile Phe Val Ile
Ile Phe Val Leu
Ile Ile Phe Val
Ile Ile Val Phe
Ile Lys Cys Lys
Ile Lys Lys Cys
Ile Leu Phe Val
Ile Leu Val Phe
Ile Pro Val Tyr
Ile Pro Tyr Val
Ile Val Phe Ile
Ile Val Phe Leu
Ile Val Ile Phe
Ile Val Leu Phe
Ile Val Pro Tyr
Ile Val Tyr Pro
Ile Tyr Pro Val
Ile Tyr Val Pro
Lys Cys Ile Lys
Lys Cys Lys Ile
Lys Cys Lys Leu
Lys Cys Leu Lys
Lys Asp Lys Thr
Lys Glu Lys Ser
Lys Glu Ser Lys
Lys Gly Met Arg
Lys Gly Arg Met
Lys Ile Cys Lys
Lys Ile Lys Cys
Lys Lys Cys Ile
Lys Lys Cys Leu
Lys Lys Asp Thr
Lys Lys Glu Ser
Lys Lys Ile Cys
Lys Lys Leu Cys
Lys Lys Ser Glu
Lys Lys Thr Asp
Lys Leu Cys Lys
Lys Leu Lys Cys
Lys Met Gly Arg
Lys Met Arg Gly
Lys Arg Gly Met
Lys Arg Met Gly
Lys Arg Ser Thr
Lys Arg Thr Ser
Lys Ser Glu Lys
Lys Ser Lys Glu
Lys Ser Arg Thr
Lys Ser Thr Arg
Lys Thr Asp Lys
Lys Thr Lys Asp
Lys Thr Arg Ser
Lys Thr Ser Arg
Leu Cys Lys Lys
Leu Phe Ile Val
Leu Phe Leu Val
Leu Phe Val Ile
Leu Phe Val Leu
Leu Ile Phe Val
Leu Ile Val Phe
Leu Lys Cys Lys
Leu Lys Lys Cys
Leu Leu Phe Val
Leu Leu Val Phe
Leu Pro Val Tyr
Leu Pro Tyr Val
Leu Val Phe Ile
Leu Val Phe Leu
Leu Val Ile Phe
Leu Val Leu Phe
Leu Val Pro Tyr
Leu Val Tyr Pro
Leu Tyr Pro Val
Leu Tyr Val Pro
Met Gly Lys Arg
Met Gly Arg Lys
Met Lys Gly Arg
Met Lys Arg Gly
Met Arg Gly Lys
Met Arg Lys Gly
Pro Ile Val Tyr
Pro Ile Tyr Val
Pro Leu Val Tyr
Pro Leu Tyr Val
Pro Val Ile Tyr
Pro Val Leu Tyr
Pro Val Tyr Ile
Pro Val Tyr Leu
Pro Tyr Ile Val
Pro Tyr Leu Val
Pro Tyr Val Ile
Pro Tyr Val Leu
Arg Gly Lys Met
Arg Gly Met Lys
Arg Lys Gly Met
Arg Lys Met Gly
Arg Lys Ser Thr
Arg Lys Thr Ser
Arg Met Gly Lys
Arg Met Lys Gly
Arg Ser Lys Thr
Arg Ser Thr Lys
Arg Thr Lys Ser
Arg Thr Ser Lys
Ser Glu Lys Lys
Ser Lys Glu Lys
Ser Lys Lys Glu
Ser Lys Arg Thr
Ser Lys Thr Arg
Ser Arg Lys Thr
Ser Arg Thr Lys
Ser Thr Lys Arg
Ser Thr Arg Lys
Thr Asp Lys Lys
Thr Lys Asp Lys
Thr Lys Lys Asp
Thr Lys Arg Ser
Thr Lys Ser Arg
Thr Arg Lys Ser
Thr Arg Ser Lys
Thr Ser Lys Arg
Thr Ser Arg Lys
Val Phe Ile Ile
Val Phe Ile Leu
Val Phe Leu Ile
Val Phe Leu Leu
Val His His Val
Val His Val His
Val Ile Phe Ile
Val Ile Phe Leu
Val Ile Ile Phe
Val Ile Leu Phe
Val Ile Pro Tyr
Val Ile Tyr Pro
Val Leu Phe Ile
Val Leu Phe Leu
Val Leu Ile Phe
Val Leu Leu Phe
Val Leu Pro Tyr
Val Leu Tyr Pro
Val Pro Ile Tyr
Val Pro Leu Tyr
Val Pro Tyr Ile
Val Pro Tyr Leu
Val Val His His
Val Tyr Ile Pro
Val Tyr Leu Pro
Val Tyr Pro Ile
Val Tyr Pro Leu
Tyr Ile Pro Val
Tyr Ile Val Pro
Tyr Leu Pro Val
Tyr Leu Val Pro
Tyr Pro Ile Val
Tyr Pro Leu Val
Tyr Pro Val Ile
Tyr Pro Val Leu
Tyr Val Ile Pro
Tyr Val Leu Pro
Tyr Val Pro Ile
Tyr Val Pro Leu
BIX01294
macrocarpal I
3-O-alpha-L-rhamnopyranosyl-3-hydroxynonanoyl-3-hydroxydecanoic acid
macrocarpal J
Verapamil hydrochloride
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Dexamethasone tebutate
butyl 2-methylprop-2-enoate,2-hydroxypropyl 2-methylprop-2-enoate,methyl 2-methylprop-2-enoate,styrene
Sapacitabine
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite D000970 - Antineoplastic Agents Sapacitabine is an orally available nucleoside analog proagent that is structurally related to cytarabine.
3α,12α-Diacetoxy-5β-cholan-24-oic acid methyl ester
Dexverapamil Hydrochloride
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker C93038 - Cation Channel Blocker
(17-acetyl-3,8,14,17-tetrahydroxy-10,13-dimethyl-1,2,3,4,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-12-yl) (E)-3,4-dimethylpent-2-enoate
(2R,3R)-8-(2-cyclohexylethynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(3-pyridinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(10R,11S)-10-[[(3-fluorophenyl)methyl-methylamino]methyl]-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one
(10R,11S)-10-[[(4-fluorophenyl)methyl-methylamino]methyl]-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one
(10R,11S)-10-[[(4-fluorophenyl)methyl-methylamino]methyl]-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one
(10R,11S)-10-[[(3-fluorophenyl)methyl-methylamino]methyl]-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one
4-[(2R,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-8-yl]benzonitrile
(10S,11R)-10-[[(3-fluorophenyl)methyl-methylamino]methyl]-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one
4-[(2R,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-8-yl]benzonitrile
4-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-8-yl]benzonitrile
(10S,11S)-10-[[(4-fluorophenyl)methyl-methylamino]methyl]-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one
(10S,11S)-10-[[(4-fluorophenyl)methyl-methylamino]methyl]-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one
(2R,3S)-8-(2-cyclohexylethynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(3-pyridinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3R)-8-(2-cyclohexylethynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(3-pyridinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3R)-8-(2-cyclohexylethynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(3-pyridinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3S)-8-(2-cyclohexylethynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(3-pyridinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3S)-8-(2-cyclohexylethynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(3-pyridinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R)-2-[(4S,5S)-8-(1-cyclohexenyl)-5-[[cyclopentylmethyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-8-[2-(4-morpholinyl)-1-oxoethyl]-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-8-[2-(4-morpholinyl)-1-oxoethyl]-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-8-[2-(4-morpholinyl)-1-oxoethyl]-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
(10S,11R)-10-[[(4-fluorophenyl)methyl-methylamino]methyl]-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one
[(1R)-7-methoxy-1-(4-oxanylmethyl)-2-(pyridin-4-ylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
(2R,3S)-8-(2-cyclohexylethynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(3-pyridinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3R)-8-(2-cyclohexylethynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(3-pyridinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(2-pyridin-4-ylethynyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S)-2-[(4R,5R)-8-(1-cyclohexenyl)-5-[[cyclopentylmethyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-8-[2-(4-morpholinyl)-1-oxoethyl]-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-8-[2-(4-morpholinyl)-1-oxoethyl]-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-8-[2-(4-morpholinyl)-1-oxoethyl]-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(5R,6S,9S)-5-methoxy-3,6,9-trimethyl-8-[2-(4-morpholinyl)-1-oxoethyl]-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-8-[2-(4-morpholinyl)-1-oxoethyl]-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
(10S,11S)-10-[[(3-fluorophenyl)methyl-methylamino]methyl]-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one
(10S,11R)-10-[[(3-fluorophenyl)methyl-methylamino]methyl]-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one
[(1S)-7-methoxy-1-(4-oxanylmethyl)-2-(pyridin-4-ylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
2,3-dihydroxypropyl [2-hydroxy-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoxy]propyl] hydrogen phosphate
[(4E,8E)-2-(butanoylamino)-3-hydroxypentadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(4E,8E)-2-acetamido-3-hydroxyheptadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(4E,8E)-3-hydroxy-2-(pentanoylamino)tetradeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(4E,8E)-3-hydroxy-2-(propanoylamino)hexadeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(4E,8E)-2-(hexanoylamino)-3-hydroxytrideca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-acetyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (Z)-tridec-9-enoate
[(4E,8E)-2-(heptanoylamino)-3-hydroxydodeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate
(1-pentanoyloxy-3-phosphonooxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate
(1-butanoyloxy-3-phosphonooxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate
(1-phosphonooxy-3-propanoyloxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate
(1-acetyloxy-3-phosphonooxypropan-2-yl) (9Z,12Z)-nonadeca-9,12-dienoate
2-[[3-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
(4E,9E)-9-(chloromethylidene)-N-[(E)-3-methoxy-5-[(2S)-2-methyl-5-oxo-2H-pyrrol-1-yl]-5-oxopent-3-enyl]-6-methyltetradeca-4,13-dienamide
10-Hydroxy-octadec-12Z-enoate-9-beta-D-glucuronide
9,11alpha-epoxy-6alpha-acetoxy-cholest-7-en-3beta,5alpha,19-triol
5,7-dihydroxy-2-(hydroxymethyl)-15-methyl-14-(6-methylheptan-2-yl)-18-oxapentacyclo[8.8.0.0¹,¹⁷.0²,⁷.0¹¹,¹⁵]octadec-9-en-8-yl acetate
3-[(1,1,4a,6-tetramethyl-5-{3-methyl-5-[(3-methylpentanoyl)oxy]pent-3-en-1-yl}-2,3,4,5,8,8a-hexahydronaphthalen-2-yl)oxy]-3-oxopropanoic acid
3,7,8-trihydroxy-4',5,5',5',19-pentamethyl-17,20-dioxaspiro[hexacyclo[14.5.1.0¹,¹⁴.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosane-18,2'-oxolan]-21-one
(2r,5r)-2-[(1s,3as,5ar,7r,8s,9ar,9br,11ar)-3a,7,8-trihydroxy-9a,11a-dimethyl-5-oxo-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-hydroxy-5,6-dimethylheptane-3,4-dione
(2s)-2-({[(2s)-1-[(2s)-2-{[(2s)-2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-3-methylbutanoyl]pyrrolidin-2-yl](hydroxy)methylidene}amino)-4-methylpentanoic acid
methyl 4-[3,4-dihydroxy-6-(hydroxymethyl)-3a,6,9a,11a-tetramethyl-7,10-dioxo-1h,2h,3h,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]pentanoate
3-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-6-yl 8-methyl-6-[(2-methylbut-2-enoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl 2-methylbut-2-enedioate
methyl (4r)-4-[(1r,3ar,4s,6s,7s,9as,11ar)-4,7-dihydroxy-6-(hydroxymethyl)-3a,6,9a,11a-tetramethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]pentanoate
1-{3'-heptyl-4-hydroxy-3h-spiro[2-benzofuran-1,2'-chromen]-5'-yl}nonan-1-one
5-(8,14-dihydroxy-14-methyl-7-oxopentadecyl)-7-hydroxy-2-(2-hydroxypropyl)chromen-4-one
3,4,7-trihydroxy-1-(6-hydroxy-4-oxoheptan-2-yl)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-10-one
(3r)-7-(3,7-dimethylocta-2,6-dien-1-yl)-5,6-dihydroxy-3-[(4-hydroxyphenyl)methyl]-8-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
methyl 5-{[(1r,4ar,5r,6s,8as)-6-hydroxy-5-(3-hydroxy-3-methylbutyl)-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methyl}-6-methoxy-2-methyl-4-oxopyran-3-carboxylate
26-nor-11,23-dioxo-5α-lanost-8-en-3β,7β,l5α,25-tetrol
{"Ingredient_id": "HBIN004959","Ingredient_name": "26-nor-11,23-dioxo-5\u03b1-lanost-8-en-3\u03b2,7\u03b2,l5\u03b1,25-tetrol","Alias": "NA","Ingredient_formula": "C29H46O6","Ingredient_Smile": "CC(CC(=O)CC(C)O)C1CC(C2(C1(CC(=O)C3=C2C(CC4C3(CCC(C4(C)C)O)C)O)C)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "42166","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
asparacosin b
{"Ingredient_id": "HBIN017093","Ingredient_name": "asparacosin b","Alias": "NA","Ingredient_formula": "C29H46O6","Ingredient_Smile": "CC1CCC2(C(C3(C(O2)CC4C3(C(=O)CC5C4CCC6C5(CCC(C6)(OC)OC)C)C)O)C)OC1","Ingredient_weight": "490.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1865","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "21575013","DrugBank_id": "NA"}